Gut-focused supplement launches and industry shifts are explored here, offering a curious look at evolving microbiome and longevity trends.
Key Takeaways
- Product combines a live Akkermansia strain with BPL1, a heat-treated clinically studied postbiotic
- BPL1 has clinical evidence for improving body composition, abdominal fat, and blood sugar metabolism
- Launch signals industry movement toward microbiome-based metabolic interventions linked to GLP-1 pathways